Connect with us

Hi, what are you looking for?


Novartis Japan unit charged over research manipulation

Novartis Japan unit charged over research manipulation/AFP

Novartis Japan unit charged over research manipulation/AFP

TOKYO, July 1 – Japanese prosecutors Tuesday laid charges against the local unit of Swiss pharmaceutical giant Novartis in a widening scandal over claims that falsified data were used to exaggerate the benefits of a popular blood pressure drug.

Prosecutors also indicted former employee Nobuo Shirahashi, 63, alleging he manipulated the data in clinical studies that were later used in marketing the drug Valsartan.

The dual charges laid by the Tokyo District Public Prosecutor’s Office — which allege that Novartis bore responsibility for Shirahashi’s actions — came several weeks after he was first arrested and authorities raided the offices of Novartis Pharma KK in the Japanese capital.

The drug studies suggested Valsartan — sold under the brand name Diovan in Japan, and licensed for use in more than 100 countries — could help prevent strokes and angina, in addition to its acknowledged benefits in combating blood pressure.

The firm used data from those studies to market its drug, playing up its supposed additional benefits.

“We take the arrest of our former employee and the indictment of our company very seriously,” the unit said in a statement on its website.

“We deeply apologise to patients, their families and medical workers as well as Japanese people for causing these concerns and trouble,” it added.

The pharmaceutical giant’s Japan unit has also been embroiled in another scandal over allegations it did not properly disclose the possible side effects of leukaemia treatments.

In April, Novartis replaced the top executives at its Japanese arm over those allegations.

Under the country’s pharmaceutical law, anyone found guilty of exaggerating advertising can face up to two years in prison or a fine of as much as two million yen ($19,000).

Advertisement. Scroll to continue reading.
Click to comment

More on Capital Business

Executive Lifestyle

NAIROBI, Kenya, Mar 12 – The country’s super wealthy individuals are increasing their holding of bonds, gold and cash, a new report by Knight...

Ask Kirubi

NAIROBI, Kenya, Mar 9 – Businessman and industrialist Dr. Chris Kirubi has urged members of the public to exercise extreme caution when making any...

Ask Kirubi

NAIROBI, Kenya, Mar 24 – Businessman and industrialist Dr. Chris Kirubi is set to own half of Centum Investment Company PLC, following a go-ahead...

Ask Kirubi

It is without a doubt that the COVID-19 pandemic has caught the whole world by surprise. Although its full impact is yet to be...


NAIROBI, Kenya, Mar 18 – Commercial Banks have been ordered to provide relief to borrowers on their personal loans, with loans eligible from March...


NAIROBI, Kenya, Jun17 – Kenya’s tea leaves manufacturer Kericho Gold, has been awarded the Superbrands Seal by Superbrands East Africa for their quality variety...


NAIROBI, Kenya, Apr 13 – As the local telecommunications industry gears up to roll out 5G networks in the country, the Communications Authority of...


NAIROBI, Kenya, Mar 22 – Airtel Kenya is offering free internet access for students in order to enable continued learning at home in the...